229 related articles for article (PubMed ID: 29582125)
1. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
[TBL] [Abstract][Full Text] [Related]
2. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
6. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
[TBL] [Abstract][Full Text] [Related]
8. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.
Lee BC; Lee HG; Park IJ; Kim SY; Kim KH; Lee JH; Kim CW; Lee JL; Yoon YS; Lim SB; Yu CS; Kim JC
Medicine (Baltimore); 2016 Sep; 95(39):e4999. PubMed ID: 27684857
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic radiofrequency ablation for the management of colorectal liver metastases: 10-year experience.
Kennedy TJ; Cassera MA; Khajanchee YS; Diwan TS; Hammill CW; Hansen PD
J Surg Oncol; 2013 Mar; 107(4):324-8. PubMed ID: 22996143
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of efficacy of radiofrequency ablation for treatment of colorectal cancer liver metastases from a Canadian perspective.
Kwan BY; Kielar AZ; El-Maraghi RH; Garcia LM
Can Assoc Radiol J; 2014 Feb; 65(1):77-85. PubMed ID: 22867961
[TBL] [Abstract][Full Text] [Related]
13. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
16. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
[TBL] [Abstract][Full Text] [Related]
18. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
[TBL] [Abstract][Full Text] [Related]
19. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
